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Background/aim: Widespread use of antiretroviral treatment (ART) has led to decrease in the incidence of HIV/AIDS-related mortality.
Besides the availability of ART, medication adherence is essential for treatment success. There is a scarcity of data reported from
Turkey regarding ART adherence among people living with HIV/AIDS (PLWHA). Therefore, this study was undertaken to determine
medication adherence and related factors among PLWHA in Turkey.
Materials and methods: The sample consisted of 158 PLWHA, who were being followed up at Infectious Diseases Outpatient Clinic of
Hacettepe University Hospital. Data were collected using an individual questionnaire and the Turkish version of the Morisky Medication
Adherence Scale.
Results: The median patient age was 38 years, 80.4% were male, and 51.3% were married. The median duration of both HIV infection
and ART was 3 years. Sixty-one percent used two drug regimens. Sixty-one percent were highly adherent to ART while 37.9% were
moderately adherent. The absence/presence of social support resources, disease duration, ART duration, and being informed about the
ART regimen were statistically associated with medication adherence.
Conclusion: Our results suggest that medication adherence is excellent among Turkish PLWHA. Interventions, including effective
social support, and continuous counseling about ART, might further boost the adherence of PLWHA.
Key words: HIV/AIDS, antiretroviral treatment, medication adherence, nursing

1. Introduction
There are 36.9 million people living with HIV/AIDS
(PLWHA) in the world. Among them, 34.3 million are
adults, and 17.4 million are women (1). According to the
Turkish Ministry of Health’s National HIV Registry, about
17,000 people are living with the HIV infection in Turkey.
However, due to the long latency, lack of adequate target
population testing, and inadequate registry systems, this
number may not be robust (2).
From 2001 to 2013, the annual number of new
HIV infections declined by 38% globally, followed by
a significant decline in AIDS-related deaths. However,
trends in new infections have differed among regions
and countries (3), and the number of new HIV diagnoses
increased 450% after 2012 in Turkey (2).
There is no cure for HIV infection. Nonetheless,
antiretroviral treatment (ART) can be implemented to
overcome the infection-associated adverse outcomes
(4,5). ART is the cornerstone of management of PLWHA.
Widespread use of ART led to a decrease in the incidence

of HIV/AIDS-related mortality both in the developed and
developing world (6). Furthermore, ART improves the
quality of life and prolongs the life expectancy (7).
Medication adherence is defined as ‘‘the act of
conforming to the recommendations made by the
provider with respect to timing, dosage, and frequency
of medication taking’’ (8). Besides the availability of ART,
medication adherence must be at least 90% to suppress
HIV replication (9–11). Medication adherence is crucial
in maintaining therapeutic drug levels, ensuring virologic
suppression, reducing drug resistance (12), preventing
immunologic decay from HIV, and, especially, reducing
the risk of HIV transmission (13).
Variation in medication adherence has been reported
among PLWHA by various studies. Data from Georgia,
Iran, Russia, and Greece suggested that the proportion of
the adherent PLWHA was 79.0%, 63.9%, 82.0%, and 81.8%,
respectively (14–17). A small and older study composed of
36 PLWHA from Turkey found the ART adherence rate as
38.9% (18).
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Risk factors associated with low medication adherence
were being busy, forgetfulness (19,20), side effects of
ART, economic problems (8), stigmatization (8,21,22),
and emotional stress (23,24). In addition, lack of central
insurance and therefore high cost is another reason for low
adherence (25). In Turkey, it is stated in the 67th article of
the Social Insurance and General Health Insurance Law
that people with any communicable diseases can benefit
from the General Health Insurance system without any
delay. HIV infection is also classified in this list. Hence,
ART and other medical costs are fully covered by the
government (26). PLWHA are charged only for a small
amount of the expenditure per prescription. It is called the
“contribution margin” and is 10% of drug price (27).
It is important to evaluate ART adherence among
PLWHA. There is a scarcity of data reported from Turkey
regarding ART adherence. This study was undertaken to
determine the medication adherence and related factors
among PLWHA in Turkey.
2. Materials and methods
2.1. Patients
This hospital-based descriptive study was conducted at
the HIV/AIDS Outpatient Clinic of Hacettepe University
Hospital in Ankara between 7 September 2015 and 27
April 2016. Hacettepe University Non-invasive Ethical
Research Board Study reviewed and approved the study
protocol (Ref. No.: 16969557-981–02.09.2016). The
researchers worked in collaboration with the clinicians
in the identification of HIV/AIDS patients, who were
receiving ART. A written statement was also included in
the introductory part of the questionnaires, explaining
the study purpose and confidentiality of the information
collected. All data were obtained from respondents in a
private room.
A total 310 PLWHA were being followed up at the
HIV/AIDS outpatient clinic. The calculated sample size
was 138, assuming α = 0.05 and 1-β = 0.95 in power
analysis. During the study period, 186 PLWHA applied
to the infectious diseases clinic for treatment and followup. Among them, 158 PLWHA who fulfilled the inclusion
criteria and voluntarily agreed to participate in the research
were included in our study. The inclusion criteria were to
be on ART for at least 6 months, at least 18 years old, and
to provide informed consent. Exclusion criteria included
not providing informed consent and not being on ART.
A total of 28 patients were excluded, as they did not meet
the inclusion criteria. As a result, 85% (n = 158) of the
PLWHA who applied to the infectious diseases clinic were
included in the final analysis (Table 1). Our results of the
158 study participants are representative of 310 PLWHA
treated in the HIV/AIDS outpatient clinic.

2.2. Data collection
Data were collected using an individual information
questionnaire and the Turkish version of the Morisky
Medication Adherence Scale (MMAS). The personal
information questionnaire was developed by the
researchers, using PubMed and Elsevier databases
(8,19,28,29). This questionnaire included 7 questions
about the participant’s demographic characteristics (sex,
age, marital status, occupation, education level, social
insurance, and economical status) and 22 questions
on medication and disease-related factors (disease
and medication duration, name and number of pills
taken, patients’ thoughts about the benefits, complexity,
taste, and number of the drugs; reasons for missing the
doses, such as being busy, side effects, vision problems,
economic problems, stigma, lack of social and health
care professionals’ supports; methods used as a reminder
of the dose time, and assessing if the patients had any
information about the usage of the drugs)
The Turkish version of the MMAS was used to determine
adherence to ART among PLWHA. The reliability and
validity studies of the Turkish version of the MMAS were
previously reported by Vural et al. (30). This scale consists
of 6 items, each being a 2-point type, implemented in
evaluating ART compliance through a face-to-face
interview. Higher scores indicate lower adherence to ART.
According to this scale, zero score implies high adherence,
1–2 points denote moderate adherence, and 3–6 points
means noncompliant.
After informing the patient about the study, the data report
form was distributed, and correspondents asked to fill the
questionnaire in a private room located at the outpatient
clinic, by paying attention to their privacy.
2.3. Statistical analysis
All analyses were performed using SPSS version 21.0 (IBM
Corp. Released 2012. IBM SPSS Statistics for Windows,
Armonk, NY, USA: IBM Corp.) and Microsoft Excel 2013.
Numbers, percentages, median, and the chi-square (χ2)
test were used in the data analysis. The Shapiro–Wilk test
was used to determine whether the data were normally
distributed. Spearman’s rho coefficient (rs) allowed
identifying whether there was an association between
age/duration of illness/duration of medication/number of
medicines used/daily dose amount, and the MMAS score.
The Mann–Whitney U and Kruskal–Wallis tests were
adopted to determine whether there was a statistically
significant difference in the MMAS score among the
groups (female/male, marital status, education level,
having/not having information about drugs, experiencing/
not experiencing side effects, presence/absence of social
support, being satisfied/dissatisfied with the healthcare
professionals, stigma, use/do not use reminders). The
statistical significance level was set at P < 0.05.
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Table 1. Distribution of the adherent and noncompliant people living with HIV/AIDS according to
descriptive statistics of demographic variables.
Adherence level

Age

Sex
Marital status
Number of drugs taken

Education

High n (%) Medium/Low n (%)

P

18–25

11 (64.7)

6 (35.3)

0.956

26–45

57 (62.0)

35 (38.0)

46–60

23 (60.5)

15 (39.5)

>60

6 (54.5)

5 (45.5)

Male

79 (62.2)

48 (37.8)

Female

18 (60.0)

12 (40.0)

Married

49 (60.5)

32 (39.5)

Single

48 (62.3)

29 (37.7)

One-drug regimen

17 (58.6)

12 (41.4)

Two-drugs regimen

63 (64.9)

34 (35.1)

Three or more drugs

17 (53.1)

15 (46.9)

Primary school and below

12 (54.5)

10 (45.5)

Secondary school

9 (45.0)

11 (55.0)

High school

17 (56.7)

13 (43.3)

Undergraduate and master degree 59 (68.6)

27 (31.4)

3. Results
There were 500 PLWHA registered in the Hacettepe
University cohort. Among them, 310 were actively under
regular follow-up. One hundred and eighty-six PLWHA
applied for follow-up during the study period. Twentyeight PLWHA were excluded, and 158 PLWHA included
in the final analysis (Figure). The median age was 38 (min:
19, max: 74), 80.4% (n = 127) were male, and 51.3% (n = 81)
were married. The median duration of both HIV infection
diagnosis and ART were 3 years. Sixty-one percent (n =
97) used two drug regimens. Table 1 summarizes the
demographic values.
Nearly all the respondents (98.7%) thought that the
drugs are beneficial for them, but 26.6% (n = 42) reported
that they missed at least one dose because of being busy.
In addition, 28.5% (n = 45) thought that the number of
the pills taken daily are too many, and 29.7% (n = 47) had
ART-related side effects. Also, 8.2% (n = 13) had problems
affording the drugs, and 17.1% (n = 27) did not have
information about the importance of adherence to ART
and how to use the drugs. Furthermore, 42.4% (n = 67)
had stigma-related problems.
Sixty-one percent (n = 97) were highly adherent to ART
while 37.9% (n = 60) were moderately adherent. Adherence
varied among the age groups. Adherent PLWHA was
64.7%, 62.0%, 60.5%, and 54.5% in the age groups 18–25,
26–45, 46–60, and over 60 years, respectively. There were
no significant differences in adherence among the age
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0.988
0.812
0.464

0.181

groups (χ2 = 0.321; P = 0.956). Medication adherence was
not associated with sex, age, marital status, education level,
and the number of prescribed drugs in the ART regimen
(P > 0.05) (Table 1).
Medication adherence differed in PLWHA who were
previously informed about ART and those who were
not. Adherence among the preinformed and uninformed
patients was 65.6% and 40.7%, respectively (Table 2).
Those who had information on the usage and importance
of ART were statistically more adherent than those who
did not have such information (χ2 = 4.856; P = 0.028).
The presence of ART-related side effects did not
affect adherence. There was no difference in medication
adherence between patients with and without side effects
(59.6% and 62.2%, respectively) (χ2 = 0.016; P = 0.899)
(Table 2). Conversely, a significant association existed
between the presence of social support and medication
adherence. PLWHA who confirmed the presence of social
support were more adherent than the PLWHA who did
not have social support (64.8% and 31.3%, respectively)
(χ2 = 5.483; P = 0.019) (Table 2).
The relationships of the MMAS score with age,
duration after diagnosis, duration of ART, number of
medications prescribed, and number of pills taken daily
were examined. A low positive correlation between
duration after diagnosis, duration of ART, and the MMAS
score was demonstrated (rs = 0.275 and 0.254, P ≤ 0.001,
respectively) (Table 3).
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Hacettepe University cohort
n = 500 registered PLWHA
190 were not under follow-up/loss to
follow-up
310 PLWHA were under regular
follow- up
Exclusion criteria
28 PLWHA omitted from the study

. PLWHA who were not willing to

after exclusion criteria

participate in the study

Final study sample

. PLWHA who had not started ART
. PLWHA who did not want to disclose

158 PLWHA
Figure. Sampling process of the study (PLWHA, people living with HIV/AIDS; ART, antiretroviral
treatment)

Table 2. Distribution of the adherent and noncompliant people living with HIV/AIDS, according to factors related
to the disease.
Adherence level

Factor
Having information about ART
Having side effects due to ART
Having social support resources

High n (%)

Medium/Low n (%) P

Yes

86 (65.6)

45 (34.4)

No

11 (40.7)

16 (59.3)

Yes

28 (59.6)

19 (40.4)

No

69 (62.2)

42 (37.8)

Yes

92 (64.8)

50 (35.2)

No

5 (31.3)

11 (68.8)

Being satisfied with healthcare professionals’ attitudes Yes

94 (61.8)

58 (38.2)

No

3 (50.0)

3 (50.0)

Yes

43 (64.2)

24 (35.8)

No

54 (59.3)

37 (40.7)

Using reminders

Yes

38 (66.7)

19 (33.3)

No

59 (58.4)

42 (41.6)

Having financial problems

Yes

8 (61.5)

5 (38.5)

No

89 (61.4)

56 (38.6)

Stigma

0.028
0.899
0.019
0.677
0.537
0.394
1.000
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Table 3. Correlation between the Morisky Medication
Adherence Scale score and selected variables

Variable

Morisky adherence score
rs

p

Age

0.028

0.724

Duration of disease

0.275

<0.001

Duration of drug usage

0.254

0.001

Number of drugs taken

0.068

0.393

Number of pills taken daily

0.134

0.094

4. Discussion
Our results revealed that 61% of PLWHA were adherent to
ART, whereas 1.3% were noncompliant. The adherence rate
in this study was higher when compared with the reported
rates in the literature. It was previously shown that 21% to
94% of PLWHA were highly adherent to ART (15,17,29,31
–35). The variance in adherence rates may result from
differences in the research method, characteristics of the
cohort, the administrative structure of the healthcare
facilities, and the social security policies of the countries.
It may also arise from the economic status of the patients,
because people living in Europe, Asia, Africa, and America
have different socioeconomic levels.
In previous studies, ART adherence was associated
with sex (23), age (36), education (19,22), economic status
(8,24,25,33), substance use (19,23,25), disease duration
(37), stigma (8,22,23,33,38), ART-related side effects
(8,38–41), satisfaction with healthcare staff (8,33,38,39),
number of pills taken daily (21,31,32,42), social support
(8,38,43), mental health (23–25,43), using reminders
(8,43), and having information prior to ART (38). In
addition, being busy, forgetfulness (19,28,44), being away
from home (41,44), lack of central insurance (25,43), and
adverse taste of medicines (45) were the most common
reasons for low adherence. After examining the reasons
for low adherence, according to the countries, the most
leading causes included being busy, being away from
home, and forgetfulness, in the USA; side effects, substance
abuse, and stigma in Europe; stigma, forgetfulness, and
substance abuse in Asia; and lastly, economic status, side
effects, satisfaction with healthcare staff, and stigma in
Africa. Mental health was the common factor that was
associated with ART adherence in all regions. In our study,
no correlations were observed between ART adherence
and age, sex, marital status, education level, economic
status, stigma, ART-related side effects, satisfaction with
healthcare staff, and the number of pills taken daily. The
fact that our sample is small, that the study is singlecentered, and that we work at the referral center for HIV/
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AIDS may have affected these results. In addition, the
small number of people with low adherence-related risk
factors, such as lack of health insurance, dissatisfaction
with healthcare personnel, and economic problems, may
have contributed to these results.
In this study, people who were previously informed
about ART adherence had higher adherence rates
compared to those who were uninformed. Our results
agree with those of Schneider et al. who demonstrated
a statistically significant relationship between having
information about ART and ART adherence (46).
Similarly, Demirkıran et al. (47) found that informing
patients about medication adherence improves adherence
among PLWHA. Providing information to PLWHA on
ART and adherence ensures taking medicine regularly,
without missing any dose, despite feeling good/bad,
having side effects, being bored of the drugs, or feeling
no need to continue the medication; thereby maintaining
the high ART adherence level. Furthermore, in a routine
daily outpatient care, every single PLWHA applying to
our clinic was informed about ART and the disease itself.
Interestingly, some of the PLWHA under our care were still
denying previous education on ART and the disease. This
finding restresses the importance of continuous medical
briefing at every visit.
Another factor that was significantly associated
with ART adherence was the absence/presence of social
support resources (Table 2) (P = 0.019). Kalichman et
al. (48) observed that patients who had lack of support
resources were less adherent to ART. In another study, in
which pharmacists talked about their experience while
working with PLWHA, lack of support resources was
the major obstacle for ART adherence (25). Our findings
are consistent with those of the previous studies in the
literature. The absence of social support increases the
feelings of anger, offense, despair, and depression in the
later stages of HIV/AIDS infection. Consequently, all of
these factors affect patients’ adherence to ART adversely.
No statistical association was found between ART
adherence and having ART-related side effects, being
satisfied/dissatisfied about the healthcare professionals,
stigma, using reminders, and economic status (P > 0.05)
(Table 2). In contrast to our findings, PLWHA who
have ART drug-related side effects (8,20,36,37,49), are
dissatisfied about health care professionals (50) and had
stigma-related problems (8,21,22) were found to be less
adherent in other studies. From this perspective, our
findings were inconsistent with those in the literature. These
discrepancies may be because most of our respondents
were satisfied with the healthcare professionals in the
HIV/AIDS Outpatient Clinic. Also, the prescribed ART
was current, and therefore most of the PLWHA did not
experience ART-related side effects. Furthermore, we
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did not use a comprehensive tool to evaluate the stigma.
Instead, it was asked with only one question in the
questionnaire form. These reasons may explain the lack of
association between stigma, ART-related side effects, being
satisfied/dissatisfied with the healthcare professionals, and
ART adherence.
In our study, weak positive correlations were
observed between disease duration, ART duration, and
ART adherence (P = 0.001) (Table 3). It was found that
taking ART for a long time could increase the motivation
for medication adherence. Our findings corroborated
the literature (36,51). When the duration of ART is
long, PLWHA become used to the drugs, require fewer
reminders, and the drugs become a regular part of their
lives. All these factors are thought to maintain a high
medication adherence among PLWHA.
This work is the first extensive study from Turkey,
determining ART adherence and related factors. Our study
was undertaken in a tertiary level referral center, with
strict case and outcome definition criteria. The prospective
study design minimized the missing data. Our sample
size is statistically sufficient to draw a conclusion on the
ART adherence among Turkish PLWHA. Conversely, the
single-center design, lack of a reliable stigma scale, and

lack of pharmacy refill dates are main limitations in our
study.
In conclusion, the absence/presence of social support
resources, disease duration, ART duration, and being
informed about the ART regimen were statistically
associated with medication adherence. Therefore, PLWHA
must be continuously informed about the ART daily
dosing regimen, as an intervention to maintain a high ART
adherence. Suggesting reminders, ensuring and searching
social support resources, and determining the factors
that negatively affect ART adherence represent the other
solutions and propositions for increasing ART adherence
within the framework of nursing. Finally, considering that
newly diagnosed patients and those who are new to ART
have relatively low drug compliance, informing PLWHA
on the use of ART should be further intensified in newly
diagnosed individuals and those who have just started
ART.
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